Korean J Obstet Gynecol.
2002 Jul;45(7):1236-1240.
A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient
- Affiliations
-
- 1Department of Obstetrics & Gynecology, College of Medicine, Soonchunhyung University, Seoul, Korea.
- 2Department of Anatomic Pathology, College of Medicine, Soonchunhyung University, Seoul, Korea.
Abstract
- Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparative Study on Hysteroscopic and Histologic Examinations of the Endometrium in Postmenopausal Women Taking Tamoxifen
- The Change of Endometrial Thickness in Tamoxifen-treated Postmenopausal Breast Cancer Patients
- The effect of adjuvant hormonal therapy on the endometrium and ovary of breast cancer patients
- Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer
- The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer
